Crinetics Pharmaceuticals Inc

Crinetics Pharmaceuticals Inc

CRNX

Market Cap$2.86B
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Crinetics Pharmaceuticals IncCrinetics Pharmaceuticals Inc-8.7--26%--
$75.50

Target Price by Analysts

133.6% upsideCrinetics Pharmaceuticals Target Price DetailsTarget Price
$0.68

Current Fair Value

97.9% downside

Overvalued by 97.9% based on the discounted cash flow analysis.

Share Statistics

Market cap$2.86 Billion
Enterprise Value$2.82 Billion
Dividend Yield$0 (0%)
Earnings per Share$-3.69
Beta0.32
Outstanding Shares93,102,000

Return

Return on Equity-
Return on Assets-
Return on Invested Capital-

Valuation & Multiples

P/E Ratio-8.65
PEG-19.41
Price to Sales-
Price to Book Ratio2.49
Enterprise Value to Revenue3706.1
Enterprise Value to EBIT-7.47
Enterprise Value to Net Income-9
Total Debt to Enterprise0.02
Debt to Equity0.04

Revenue Sources

No data

Insider Trades

ESG Score

No data

About Crinetics Pharmaceuticals Inc

CEO: R. Scott Struthers